Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2000 1
2007 1
2008 2
2009 2
2010 2
2011 5
2012 5
2013 7
2014 8
2015 8
2016 9
2017 12
2018 8
2019 12
2020 16
2021 19
2022 15
2023 16
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Results by year

Filters applied: . Clear all
Page 1
Exercise and Neuropathy: Systematic Review with Meta-Analysis.
Streckmann F, Balke M, Cavaletti G, Toscanelli A, Bloch W, Décard BF, Lehmann HC, Faude O. Streckmann F, et al. Sports Med. 2022 May;52(5):1043-1065. doi: 10.1007/s40279-021-01596-6. Epub 2021 Dec 29. Sports Med. 2022. PMID: 34964950
Current data further support the hypothesis that exercise is beneficial for neuropathic patients. This is best documented for patients with diabetic peripheral neuropathy (DPN) (27 studies) as well as for chemotherapy-induced peripheral neuropathy (CIPN) (nin …
Current data further support the hypothesis that exercise is beneficial for neuropathic patients. This is best documented for patients with …
Effects of GLP-1 receptor agonists on neurological complications of diabetes.
García-Casares N, González-González G, de la Cruz-Cosme C, Garzón-Maldonado FJ, de Rojas-Leal C, Ariza MJ, Narváez M, Barbancho MÁ, García-Arnés JA, Tinahones FJ. García-Casares N, et al. Rev Endocr Metab Disord. 2023 Aug;24(4):655-672. doi: 10.1007/s11154-023-09807-3. Epub 2023 May 26. Rev Endocr Metab Disord. 2023. PMID: 37231200 Free PMC article. Review.
Exenatide, dulaglutide and liraglutide improved general cognition but no significant effect on diabetic peripheral neuropathy has been reported with GLP-1 RAs. GLP-1 RAs are promising drugs that seem to be useful in the reduction of some neurological complica …
Exenatide, dulaglutide and liraglutide improved general cognition but no significant effect on diabetic peripheral neuropat …
Footwear and insole design features for offloading the diabetic at risk foot-A systematic review and meta-analyses.
Collings R, Freeman J, Latour JM, Paton J. Collings R, et al. Endocrinol Diabetes Metab. 2020 Apr 11;4(1):e00132. doi: 10.1002/edm2.132. eCollection 2021 Jan. Endocrinol Diabetes Metab. 2020. PMID: 33532602 Free PMC article. Review.
The aim of this systematic review was to identify the best footwear and insole design features for offloading the plantar surface of the foot to prevent foot ulceration in people with diabetic peripheral neuropathy. We searched multiple databases for publishe …
The aim of this systematic review was to identify the best footwear and insole design features for offloading the plantar surface of the foo …
Efficacy and Safety of Mecobalamin on Peripheral Neuropathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Sawangjit R, Thongphui S, Chaichompu W, Phumart P. Sawangjit R, et al. J Altern Complement Med. 2020 Dec;26(12):1117-1129. doi: 10.1089/acm.2020.0068. Epub 2020 Jul 21. J Altern Complement Med. 2020. PMID: 32716261
Results: Fifteen studies with 1707 peripheral neuropathy patients caused by diabetic peripheral neuropathy and herpetic neuropathy were included. ...
Results: Fifteen studies with 1707 peripheral neuropathy patients caused by diabetic peripheral neuropathy and herpetic …
Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia.
Lunn MP, Hughes RA, Wiffen PJ. Lunn MP, et al. Cochrane Database Syst Rev. 2014 Jan 3;2014(1):CD007115. doi: 10.1002/14651858.CD007115.pub3. Cochrane Database Syst Rev. 2014. PMID: 24385423 Free PMC article. Review.
Duloxetine at 60 mg daily is effective in treating painful diabetic peripheral neuropathy in the short term, with a risk ratio (RR) for 50% pain reduction at 12 weeks of 1.73 (95% CI 1.44 to 2.08). ...In fibromyalgia, there is lower quality evidence that dulo …
Duloxetine at 60 mg daily is effective in treating painful diabetic peripheral neuropathy in the short term, with a ris …
Neuropathic pain in the general population: a systematic review of epidemiological studies.
van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N. van Hecke O, et al. Pain. 2014 Apr;155(4):654-662. doi: 10.1016/j.pain.2013.11.013. Epub 2013 Nov 26. Pain. 2014. PMID: 24291734 Review.
We categorised comparable incidence and prevalence rates into 2 main subgroups: (1) chronic pain with neuropathic characteristics (range 3-17%), and (2) neuropathic pain associated with a specific condition, including postherpetic neuralgia (3.9-42.0/100,000 person-years [PY]), t …
We categorised comparable incidence and prevalence rates into 2 main subgroups: (1) chronic pain with neuropathic characteristics (range 3-1 …
Electrophysiological measurements of diabetic peripheral neuropathy: A systematic review.
Shabeeb D, Najafi M, Hasanzadeh G, Hadian MR, Musa AE, Shirazi A. Shabeeb D, et al. Diabetes Metab Syndr. 2018 Jul;12(4):591-600. doi: 10.1016/j.dsx.2018.03.026. Epub 2018 Mar 28. Diabetes Metab Syndr. 2018. PMID: 29610062 Review.
METHOD: In this research, using a review design, we reviewed the issue of clinical electrophysiological examination of diabetic peripheral neuropathy in articles from 2008 to 2017. For this purpose, PubMed, Scopus and Embase databases of journals were used fo …
METHOD: In this research, using a review design, we reviewed the issue of clinical electrophysiological examination of diabetic pe …
Systematic review of treatments for diabetic peripheral neuropathy.
Çakici N, Fakkel TM, van Neck JW, Verhagen AP, Coert JH. Çakici N, et al. Diabet Med. 2016 Nov;33(11):1466-1476. doi: 10.1111/dme.13083. Epub 2016 Feb 21. Diabet Med. 2016. PMID: 26822889 Review.
AIM: To evaluate treatment options for neuropathic pain and sensory symptoms resulting from diabetic peripheral neuropathy of the feet. METHODS: The databases PubMed, Embase and Web-of-Science were searched for randomized controlled trials, published in the p …
AIM: To evaluate treatment options for neuropathic pain and sensory symptoms resulting from diabetic peripheral neuropathy …
Alpha-lipoic acid for diabetic peripheral neuropathy.
Baicus C, Purcarea A, von Elm E, Delcea C, Furtunescu FL. Baicus C, et al. Cochrane Database Syst Rev. 2024 Jan 11;1(1):CD012967. doi: 10.1002/14651858.CD012967.pub2. Cochrane Database Syst Rev. 2024. PMID: 38205823 Review.
BACKGROUND: Diabetic peripheral neuropathy (DPN) is a frequent complication in people living with type 1 or type 2 diabetes. ...OBJECTIVES: To assess the effects of alpha-lipoic acid as a disease-modifying agent in people with diabetic peripheral …
BACKGROUND: Diabetic peripheral neuropathy (DPN) is a frequent complication in people living with type 1 or type 2 diab …
Interventions for promoting physical activity in people with neuromuscular disease.
Jones K, Hawke F, Newman J, Miller JA, Burns J, Jakovljevic DG, Gorman G, Turnbull DM, Ramdharry G. Jones K, et al. Cochrane Database Syst Rev. 2021 May 24;5(5):CD013544. doi: 10.1002/14651858.CD013544.pub2. Cochrane Database Syst Rev. 2021. PMID: 34027632 Free PMC article.
A physical activity programme (weight-bearing) compared to no physical activity programme One study involved adults with diabetic peripheral neuropathy (DPN) and reported weekly duration of walking during and at the end of a one-year intervention using a Step …
A physical activity programme (weight-bearing) compared to no physical activity programme One study involved adults with diabetic …
133 results